Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Return on Invested Capital (2016 - 2019)

Aptevo Therapeutics (APVO) has disclosed Return on Invested Capital for 3 consecutive years, with 0.76% as the latest value for Q3 2019.

  • Quarterly Return on Invested Capital changed N/A to 0.76% in Q3 2019 from the year-ago period, while the trailing twelve-month figure was 0.76% through Sep 2019, changed N/A year-over-year, with the annual reading at 2311.11% for FY2017, 52333.0% up from the prior year.
  • Return on Invested Capital hit 0.76% in Q3 2019 for Aptevo Therapeutics, down from 1788.26% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 1788.26% in Q4 2017 to a low of 2.24% in Q1 2017.
  • Historically, Return on Invested Capital has averaged 197.48% across 3 years, with a median of 0.76% in 2019.
  • Biggest YoY gain for Return on Invested Capital was 179049bps in 2017; the steepest drop was -164bps in 2017.
  • Year by year, Return on Invested Capital stood at 2.23% in 2016, then soared by 80470bps to 1788.26% in 2017, then crashed by -100bps to 0.76% in 2019.
  • Business Quant data shows Return on Invested Capital for APVO at 0.76% in Q3 2019, 1788.26% in Q4 2017, and 0.71% in Q3 2017.